HLA-C and hyperlipidemia: Furthermore, although APS treatment significantly reversed the serum hyperlipidemia in db/db mice to the normal serum lipid levels of MHC-PPARα mice, there was no difference in the evident TAG accumulation between APS-treated db/db hearts and APS-treated MHC-PPARα hearts (Figure 2 and 3).